Company Overview of Evonik Corporation
Evonik Corporation manufactures and supplies specialty chemicals. It offers specialty chemicals for various applications in agriculture; automotive, transportation, and machinery; metals and mining, and oil and gas; pharmaceuticals and healthcare; printing, paints, and coatings; pulp, paper, and packaging; plastics and general industry; environment and utilities; home, lifestyle, and personal; care food, feed, and beverages; electronics and telecommunications; and construction markets. Evonik Corporation was formerly known as Evonik Degussa Corporation and changed its name to Evonik Corporation on January 1, 2013. The company was founded in 1977 and is based in Parsippany, New Jersey with ad...
299 Jefferson Road
Parsippany, NJ 07054
Founded in 1977
Key Executives for Evonik Corporation
President of Coatings & Additives Business Unit
Chief Financial Officer for North America
Head of Consumer Specialties Americas
Head of The Consumer Specialties Business Unit
Compensation as of Fiscal Year 2014.
Evonik Corporation Key Developments
Evonik Unveils High Temperature Polyamide Extrusion VESTAMID® DX9360
Mar 19 15
Evonik unveiled high temperature polyamide extrusion VESTAMID® DX9360 product. Evonik will present its new VESTAMID® DX9360 product, a polyamide extrusion compound for tubing systems that has the potential to significantly extend the lifetime of engine lines at NPE2015: The International Plastics Showcase. Tubing made from Evonik`s new high temperature resistant VESTAMID® DX9360 compound can replace rubber hoses in encapsulated engine compartments, saving space and weight.
Evonik Corporation Reports Earnings Results for 2014; Provides Earnings Guidance for 2015
Mar 3 15
Evonik Corporation reported earnings results for 2014. For the year, the company reported grew sales 2% to €12.9 billion compared with €12.7 billion for 2013. Adjusted EBITDA was €1.9 billion compared with €2.0 billion for 2013. Net income was €568 million compared with €2,054 million, boosted by the proceeds from the sale of the real estate business. Adjusted net income was €740 million compared with €806 million for 2013. Adjusted earnings per share were €1.59 compared with €1.73 for 2013.
The company expects to report slightly higher sales for fiscal 2015 (2014: €12.9 billion). Adjusted EBITDA should also be slightly higher than in the previous year (2014: €1,867 million).
Evonik Corporation Presents at BIO-Europe Spring 2015, Mar-09-2015
Jan 29 15
Evonik Corporation Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|